Effects of guancydine on catecholamine synthesis storage and catabolism.
D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D002395:Catecholamines / Q000378:metabolism*; D004952:Esters / Q000494:pharmacology; D006018:Glycols / Q000378:metabolism; D006145:Guanethidine / Q000494:pharmacology; D006146:Guanidines / Q000494:pharmacology*; D006973:Hypertension / Q000139:chemically induced / Q000235:genetics; D007700:Kinetics; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D051379:Mice; D008815:Mice, Inbred Strains; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D012110:Reserpine / Q000494:pharmacology; D014316:Tritium; D014443:Tyrosine / Q000378:metabolism
D000305:Adrenal Cortex Hormones; D000959:Antihypertensive Agents; D002395:Catecholamines; D004952:Esters; D006018:Glycols; D006146:Guanidines; D008781:Methyltyrosines; D008996:Monoamine Oxidase Inhibitors; D014316:Tritium; D014443:Tyrosine; D012110:Reserpine; D009638:Norepinephrine; D006145:Guanethidine